These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7505843)

  • 1. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
    Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
    J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective gene therapy of malignant gliomas using brain-specific promoters: its efficacy and basic investigations].
    Shimizu K
    Nihon Rinsho; 1994 Nov; 52(11):3053-8. PubMed ID: 7527868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.
    Miyao Y; Shimizu K; Tamura M; Akita H; Ikeda K; Mabuchi E; Kishima H; Hayakawa T; Ikenaka K
    Jpn J Cancer Res; 1997 Jul; 88(7):678-86. PubMed ID: 9310141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line.
    Short MP; Choi BC; Lee JK; Malick A; Breakefield XO; Martuza RL
    J Neurosci Res; 1990 Nov; 27(3):427-39. PubMed ID: 2129047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
    de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
    J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene.
    Vandier D; Rixe O; Brenner M; Gouyette A; Besnard F
    Cancer Res; 1998 Oct; 58(20):4577-80. PubMed ID: 9788604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of brain-specific gene expression in brain cells in primary culture: a novel promoter assay based on the use of a retrovirus vector.
    Ikenaka K; Nakahira K; Nakajima K; Fujimoto I; Kagawa T; Ogawa M; Mikoshiba K
    New Biol; 1992 Jan; 4(1):53-60. PubMed ID: 1536830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy against an experimental glioma using adeno-associated virus vectors.
    Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
    Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
    Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
    Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.
    Ezzeddine ZD; Martuza RL; Platika D; Short MP; Malick A; Choi B; Breakefield XO
    New Biol; 1991 Jun; 3(6):608-14. PubMed ID: 1655012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
    Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
    Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specificity of the myelin basic protein gene promoter studied in transgenic mice.
    Asipu A; Mellor AL; Blair GE
    Biochem Biophys Res Commun; 2001 Nov; 288(4):809-18. PubMed ID: 11688980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
    Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.